If there is an actual risk of transmission, the doctor may prescribe a 28-day course of HIV medications known as post-exposure prophylaxis (PEP). If started within 72 hours of a suspected exposure, ...

Popovic N, Yang Q, Campeau L, Elliott J, Williams A, Lima VD, Sereda P, Cox J. The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018 ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...

Many HIV/AIDS researchers are now hopeful that the drug, lenacapavir, will powerfully drive down global infection rates when used as pre-exposure prophylaxis (PrEP), the journal said. "It has the ...

As the United States aims to increase early diagnosis and treatment of people with HIV, a greater focus has been placed on determining the accuracy of HIV tests in real-world settings—not only to ...

Elena Vaughan received funding from the Irish Research Council for her research on HIV stigma in Irish healthcare settings. Speaking at the 16th International Aids Conference in 2006, the then ...

However, government data shows that only 13% of key populations are aware of pre-exposure prophylaxis, and just 60% know that HIV testing is free. "The high rate of late diagnoses underscores the ...

Despite the clear benefit of dihydroartemisinin–piperaquine prophylaxis against malaria, the high incidence of non-malaria events means that a formal policy switch from dihydroartemisinin–piperaquine ...

If a person thinks HIV exposure is possible, it is important to consult with a healthcare professional for advice and to ask them about a preventive medication called postexposure prophylaxis (PEP).

Scientists say they have successfully eliminated HIV from infected cells, using Nobel Prize-winning Crispr gene-editing technology. Working like scissors, but at the molecular level, it cuts DNA ...

HIV pre-exposure prophylaxis (HIV-PrEP) is effective in reducing the likelihood of HIV acquisition in HIV-negative people at high risk of exposure. Guidelines recommend testing for sexually ...